Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma
Recruiting
N/A
Interventional Study
Multiple Myeloma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Instituto do Cancer do Estado de São Paulo · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Multiple myeloma is a plasma cell neoplasm that can cause painful bone lesions. The main treatment for these lesions and pain control is radiotherapy, usually in daily fractions. In 2017, a phase III study proved the effectiveness of using a single dose of 8 Gy, but without description of several important oncological outcomes. This is a single-arm prospective cohort study. This study aims to desc…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Biopsy of plasma cell neoplasm with bone lesion treatable with radiotherapy;
* Age between 18 and 85 years old;
* Performance on the ECOG scale less than or equal to 2.
* Not using systemic therapies for 4 weeks OR being on maintenance therapy with the same drug for at least 4…
Contacts